| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Marketing > Preaching to the Converted: Keeping the Conversion Process Going |
|
Advice You - Preaching to the Converted: Keeping the Conversion Process Going
Does the conversion process end at the point of sale? Those of us in service industries rea According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product lize that the conversion process is ongoing as we have to ensure customer satisfaction in o ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in rder to continue to get repeat business. But even for those in retail or selling products o lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. f some sort, the conversation may be the end of one sales process, but it should also be th here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe e beginning of another. In the service industry, once you've got a client, he or she is yo d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro urs to lose. That means that unless you screw something up, they'll remain as a client for ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc as long as there is a need for your services. But it's also your job to continue to sell to easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi them by providing the best service possible and making sure the results are more than mere nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ly satisfactory. Cultivating your Clients Providing quality services can net you f and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ar more than just an ongoing contract, it can also provide great word-of-mouth leading to s ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ores of referrals, which is the most lucrative form of marketing. What you say about yourse ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a lf is not nearly as important as what others are saying about you. Cultivating your existi dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ng clients can result in a great source of new clients. This is also true in retail. Anytim cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin e you sell a product, name and contact information can be gathered and used to cultivate th tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen at contact, providing a means to deliver additional information about your products, offer, t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel etc. Once a customer has bought from you; there is a good chance he or she will buy from ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust you again, provided that the experience was positive. If you don't do any follow up, there y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products is a good chance that you’ll miss the boat the next time that customer needs your product. . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de So while conversions are the endpoint of a single process, with proper cultivation, follow elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip -up and relationship building, the end of one conversion will result in many more to follow tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Search for the most Happening Product in Demand The Fear Factor In Starting A Home Business
|